Padman Raj, McColley Susanna A, Miller Dave P, Konstan Michael W, Morgan Wayne J, Schechter Michael S, Ren Clement L, Wagener Jeffrey S
Department of Pediatrics, Alfred I. duPont Hospital for Children, Nemours Children's Clinic, Wilmington, DE 19899, USA.
Pediatrics. 2007 Mar;119(3):e531-7. doi: 10.1542/peds.2006-1414.
Previous analyses of the Epidemiologic Study of Cystic Fibrosis database revealed that sites with the highest average patient lung function monitor patients and treat with antibiotics more aggressively than those where average lung function is lowest. The aim of this study was to assess whether patterns of care for infants at cystic fibrosis sites with superior average lung function in 6- to 12-year-old children showed any differences from those at the lowest outcome sites.
We divided cystic fibrosis sites with > or = 20 patients who were 6 to 12 years of age into quartiles on the basis of median forced expiratory volume in 1 second of that age group in 2003 and compared demographic and clinical characteristics and treatment patterns during the first year of enrollment for patients who were aged 0 to 3 years at those sites in 1994 to 1999. The analysis included 755 infants from 12 upper quartile sites and 743 infants from 12 lower quartile sites.
Upper quartile sites had more infants whose disease was diagnosed by family history or newborn screening, fewer infants with symptoms at diagnosis, higher weight for age at enrollment, more white patients, and more deltaF508 homozygotes. Medical conditions and respiratory tract microbiology differed between sites. Infants at upper quartile sites had more office and sick visits; more respiratory tract cultures; and more frequent use of intravenous antibiotics, oral corticosteroids, mast cell stabilizers, and mucolytics; but they received less chest physiotherapy, inhaled bronchodilators, oral nutritional supplements, and pancreatic enzymes.
Both enrollment characteristics and infant care patterns are associated with lung function outcomes in later childhood. Our analysis suggests that pulmonary function of older children may be improved through specific interventions during the first 3 years of life.
先前对囊性纤维化流行病学研究数据库的分析显示,平均患者肺功能最高的地区比平均肺功能最低的地区更积极地监测患者并使用抗生素进行治疗。本研究的目的是评估6至12岁儿童平均肺功能较好的囊性纤维化治疗点与最差治疗点对婴儿的护理模式是否存在差异。
我们将2003年该年龄组1秒用力呼气量中位数≥20例6至12岁患者的囊性纤维化治疗点分为四分位数,并比较了1994年至1999年在这些治疗点0至3岁患者入组第一年的人口统计学和临床特征以及治疗模式。分析包括来自12个上四分位数治疗点的755名婴儿和来自12个下四分位数治疗点的743名婴儿。
上四分位数治疗点有更多通过家族病史或新生儿筛查确诊疾病的婴儿,诊断时有症状的婴儿较少,入组时年龄别体重较高,白人患者较多,以及更多的ΔF508纯合子。各治疗点的医疗状况和呼吸道微生物学存在差异。上四分位数治疗点的婴儿有更多的门诊和病假就诊;更多的呼吸道培养;更频繁地使用静脉抗生素、口服皮质类固醇、肥大细胞稳定剂和黏液溶解剂;但他们接受的胸部物理治疗、吸入支气管扩张剂、口服营养补充剂和胰酶较少。
入组特征和婴儿护理模式均与儿童后期的肺功能结果相关。我们的分析表明,通过生命最初3年的特定干预,大龄儿童的肺功能可能会得到改善。